Henrike E Karim-Kos

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. doi request reprint Progress against cancer in the Netherlands since the late 1980s: an epidemiological evaluation
    Henrike E Karim-Kos
    Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Int J Cancer 130:2981-9. 2012
  2. doi request reprint Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s
    Henrike E Karim-Kos
    Department of Public Health, Erasmus MC University Medical Centre Rotterdam, Room AE 107, P O Box 2040, 3000 CA Rotterdam, Netherlands
    Eur J Cancer 44:1345-89. 2008
  3. doi request reprint The beginning of the end of the lung cancer epidemic in Dutch women?
    Henrike E Karim-Kos
    Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands
    Int J Cancer 123:1472-5. 2008
  4. ncbi request reprint [The beginning of the end of the lung cancer epidemic among Dutch women]
    H E Karim-Kos
    Erasmus MC Centrum, afd Maatschappelijke Gezondheidszorg, Postbus 2040, 3000 CA Rotterdam
    Ned Tijdschr Geneeskd 152:1473-7. 2008
  5. pmc Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival
    Caroline D M Witjes
    Department of Hepatobiliary and Transplantation Surgery, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands
    HPB (Oxford) 14:777-81. 2012
  6. doi request reprint Gallbladder cancer in the Netherlands: incidence, treatment and survival patterns since 1989
    Caroline D M Witjes
    Department of Hepatobiliary and Transplantation Surgery, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Dig Surg 29:92-8. 2012
  7. doi request reprint Lower mortality from nasopharyngeal cancer in The Netherlands since 1970 with differential incidence trends in histopathology
    Melina Arnold
    Department of Public Health, Erasmus MC, University Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Oral Oncol 49:237-43. 2013
  8. doi request reprint Explanations for worsening cancer survival
    Esther De Vries
    Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Nat Rev Clin Oncol 7:60-3. 2010
  9. doi request reprint Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival
    Caroline D M Witjes
    Department of Hepatobiliary and Transplantation Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Eur J Gastroenterol Hepatol 24:450-7. 2012
  10. doi request reprint Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached?
    Inge M C M de Kok
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Int J Cancer 128:2174-81. 2011

Collaborators

Detail Information

Publications12

  1. doi request reprint Progress against cancer in the Netherlands since the late 1980s: an epidemiological evaluation
    Henrike E Karim-Kos
    Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Int J Cancer 130:2981-9. 2012
    ..Our conceptual framework limits misinterpretations from separate trends and generates a more balanced discussion on progress...
  2. doi request reprint Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s
    Henrike E Karim-Kos
    Department of Public Health, Erasmus MC University Medical Centre Rotterdam, Room AE 107, P O Box 2040, 3000 CA Rotterdam, Netherlands
    Eur J Cancer 44:1345-89. 2008
    ..We present a comprehensive overview of most recent European trends in population-based incidence of, mortality from and relative survival for patients with cancer since the mid 1990s...
  3. doi request reprint The beginning of the end of the lung cancer epidemic in Dutch women?
    Henrike E Karim-Kos
    Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands
    Int J Cancer 123:1472-5. 2008
    ....
  4. ncbi request reprint [The beginning of the end of the lung cancer epidemic among Dutch women]
    H E Karim-Kos
    Erasmus MC Centrum, afd Maatschappelijke Gezondheidszorg, Postbus 2040, 3000 CA Rotterdam
    Ned Tijdschr Geneeskd 152:1473-7. 2008
    ..To describe and interpret recent changes in lung cancer mortality and incidence, and changes in smoking prevalence among young and middle-aged women in The Netherlands...
  5. pmc Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival
    Caroline D M Witjes
    Department of Hepatobiliary and Transplantation Surgery, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands
    HPB (Oxford) 14:777-81. 2012
    ..To explore trends in the incidence and survival of patients with intrahepatic cholangiocarcinoma (ICC) an unselected population in Western Europe was studied...
  6. doi request reprint Gallbladder cancer in the Netherlands: incidence, treatment and survival patterns since 1989
    Caroline D M Witjes
    Department of Hepatobiliary and Transplantation Surgery, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Dig Surg 29:92-8. 2012
    ..To examine recent trends in gallbladder cancer (GBC) in the general population in the Western world, cancer registration data on GBC in the Netherlands were analyzed...
  7. doi request reprint Lower mortality from nasopharyngeal cancer in The Netherlands since 1970 with differential incidence trends in histopathology
    Melina Arnold
    Department of Public Health, Erasmus MC, University Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Oral Oncol 49:237-43. 2013
    ..We studied trends in NPC incidence, tumour morphology, survival and mortality in order to assess progress against this cancer...
  8. doi request reprint Explanations for worsening cancer survival
    Esther De Vries
    Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Nat Rev Clin Oncol 7:60-3. 2010
    ..In this article, we identify the pitfalls that might be encountered in comparisons of published, population-based survival data from different time periods or populations...
  9. doi request reprint Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival
    Caroline D M Witjes
    Department of Hepatobiliary and Transplantation Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Eur J Gastroenterol Hepatol 24:450-7. 2012
    ..To examine recent trends in incidence and outcome among patients with hepatocellular carcinoma (HCC) in an unselected population in Western Europe...
  10. doi request reprint Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached?
    Inge M C M de Kok
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Int J Cancer 128:2174-81. 2011
    ..On top of that there was an extra decrease that was compensated by a following recent increase in incidence, probably resulting from reorganization of the Dutch screening program...
  11. doi request reprint Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008
    Dorry Boll
    Department of Gynaecology, TweeSteden Hospital, Tilburg, The Netherlands
    Int J Gynecol Cancer 22:599-606. 2012
    ..We examined the incidence and survival of patients with uncommon epithelial tumors, carcinosarcomas, and sarcomas of the corpus uteri diagnosed since 1989...
  12. ncbi request reprint HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma
    Arjan Diepstra
    Department of Pathology and Laboratory Medicine, University Medical Center Groningen, University of Groningen, The Netherlands
    J Clin Oncol 25:3101-8. 2007
    ..The neoplastic Hodgkin Reed-Sternberg (HRS) cells in classical Hodgkin's lymphoma (cHL) are derived from B cells. The frequency of HLA class II downregulation and its effect on prognosis are unknown...